NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue:
Hemoglobin A1c Monitoring - Global Market Trends
Advertisement
http://www.reportlinker.com/p0164230/Hemoglobin-A1c-Monitoring---Global-Market-Trends.html
The seriousness of affliction and the need for effective therapy to manage diabetes has led to the emergence of a significant market for monitoring the treatment efficiency of the disease. Other factors such as greater glucose control, product innovations that help improve compliance or convenience comprise other growth drivers in hemoglobin A1C monitoring market.
Advertisement
Diabetes patients (Type I) who regularly monitor their HbA1c (hemoglobin A1C) levels attain tight glucose control, thus considerably reducing their vulnerability to a cardiovascular disease. High blood sugar level for a longer period of time could result to increase in risk of heart disease or stroke. An HBA1C level more that 4.6 indicate the person is at increased risk for heart attack. The ADA (American Diabetes Association), recommends an HbA1c test every 3 to 6 months for monitoring the levels of blood sugar in insulin-administered patients, patients with high blood glucose levels and patients with a change of therapy.
These and other market data and trends are presented in "Hemoglobin A1c Monitoring: Global Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
HEMOGLOBIN A1c MONITORING BMR-1030
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. MARKET OVERVIEW 4
Diabetes Monitoring Market 4
Higher Levels of Glycosylated Hemoglobin Increases the Risk of
Death 4
Regular HbA1c Test Keeps Heart Risk at Bay 5
Home Monitoring 5
3. PRODUCT FACTS 6
HbA1c Laboratory Testing 6
HbA1c Point of Care Testing & Self- Monitoring 6
4. TECHNOLOGICAL DEVELOPMENTS 7
New Noninvasive Monitoring and Testing Devices 7
HGI as a Statistical Predictor of Nephropathy and Retinopathy 8
Micro-Optical Detection Method Technology - Metrika 8
5. REGULATORY ENVIRONMENT 9
Animas Obtains FDA Approval for OneTouch Glucose Management
System 9
ARKRAY USA Obtains FDA Approval for GLUCOCARD 9
Bayer's Breeze Blood Glucose Monitoring System Receives
Commendation 10
Trinity Biotech Obtains FDA Approval for Point of Care HbA1c Test 10
MedApps Receives FDA Clearance for OTC Use of D-PAL Remote System 11
DexCom Receives FDA Approval for STS-7 System 11
Diazyme's Direct Enzymatic HbA1c Assay Kit Receives FDA Clearance 11
Trinity Biotech Receives FDA Approval for TRIstat HbA1c Test 11
6. CORPORATE DEVELOPMENTS 12
Roche Inks Marketing Agreement with Mankind Pharma 12
Nicholas Piramal Forms Joint Venture with Arkray 12
Quotient Diagnostics to Commence Production of Quo-Test System 12
Pelikan and Eli Lilly Sign Co-Promotion Agreement 13
Quantimetrix Develops GlycoHemosure 13
Olympus Life Science Europa Unveils HbA1c assay 13
Siemens Healthcare Introduces DCA Vantage(TM) Analyser 14
Sysmex America and Bio-Rad Sign Long-term Distribution Agreement 15
Medtronic Enters in to Alliance with Bayer HealthCare 15
Inverness Snaps Up Cholestech 15
IQ Micro to Complete Lifecare Acquisition 16
Bio-Rad Introduces The in2it Analyzer 16
Abbott Diabetes Launches FreeStyle Lite(TM) Blood Glucose Meter 16
Bayer Introduces BREEZE®2 and CONTOUR® Blood Glucose Meters 17
ARKRAY Introduces PocketChem(TM)EZ Blood Glucose Monitoring System 17
Abbott Rolls Out New Blood Glucose Monitoring Devices 17
Axis-Shield UK Introduces Afinion(TM) 18
Medtronic Plans Launch of Online Testing Kit for Diabetes 18
Nova Biomedical Launches Nova Max(TM) Blood Glucose Monitoring
System 18
Medtronic Announces Launch of New Continuous Glucose
Monitoring System 19
LifeScan Offers Meter Upgrade for OneTouch® Blood Glucose
Monitoring Systems 19
7. MAJOR PLAYERS 20
Abbott Laboratories (USA) 20
Axis-Shield (UK) 20
Bayer Healthcare Diabetes Care (USA) 20
Beckman Coulter, Inc. (USA) 20
Bio-Rad Laboratories Inc (USA) 21
Biosafe Laboratories Inc (USA) 21
Diabetes Technologies Inc (USA) 21
Flexsite Diagnostics Inc (USA) 21
Primus Diagnostics (USA) 22
Roche Diagnostics (Switzerland) 22
Tosoh Bioscience, Inc (USA) 22
8. GLOBAL MARKET ANALYTICS 23
9. THE UNITED STATES 26
An Insight 26
Market Highlights 26
Challenges in the HbA1c Monitoring Market in the US 27
Market Trends & Issues 27
Impact of Pricing and Innovation 27
HbA1c Monitoring Vs Blood Glucose Monitoring 28
Impact Of Diabetes Education Campaigns On HbA1c Monitors Usage 28
Impact of Sedentary Lifestyle 28
Reimbursements from Managed Care Organizations 28
The Diabetes A1c Initiative(TM) 28
10. CANADA 30
11. JAPAN 31
12. EUROPE 32
a. France 35
b. Germany 36
c. Italy 37
d. The United Kingdom 38
e. Spain 39
f. Russia 40
g. Rest of Europe 41
13. ASIA-PACIFIC 42
14. MIDDLE EAST 43
15. LATIN AMERICA 44
16. REST OF WORLD 45
EXHIBITS
Table 1: Global HbA1c Monitoring Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 2: Percentage Breakdown of Global HbA1c Monitoring
Market by Region for the Years 2008 & 2012
Table 3: Global HbA1c Laboratory Testing Market by Region for
the Period 2007- 2015 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global HbA1c Laboratory
Testing Market by Region for the Years 2008 & 2012
Table 5: Global HbA1c Point of Care Testing & Self-Monitoring
Market by Region for the Period 2007-2015 (Sales in US$
Million)
Table 6: Percentage Breakdown of Global HbA1c Point of Care
Testing & Self- Monitoring Market by Region for the Years 2008
& 2012
Table 7: Percentage Breakdown of HbA1c Point of Care Testing
Equipment Manufacturer Revenues in the US - 2005
Table 8: Percentage Breakdown of HbA1c Laboratory Testing
Equipment Manufacturer Revenues in the US - 2007
Table 9: The US Market for HbA1c Monitoring by Type: 2007-2015
(Sales in US$ Million)
Table 10: Percentage Breakdown of the US Market for HbA1c
Monitoring by Type for the Years 2008 & 2012
Table 11: The Canadian Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of the Canadian Market for
HbA1c Monitoring by Type for the Years 2008 & 2012
Table 13: The Japanese Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown of the Japanese Market for
HbA1c Monitoring by Type for the Years 2008 & 2012
Table 15: HbA1c Monitoring Market by Region in Europe:
2007-2015 (Sales in US$ Million)
Table 16: Percentage Breakdown of HbA1c Monitoring Market by
Region in Europe for the Years 2008 & 2012
Table 17: The European Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 18: Percentage Breakdown of the European Market for
HbA1c Monitoring by Type for the Years 2008 & 2012
Table 19: The French Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 20: Percentage Breakdown of the French Market for HbA1c
Monitoring by Type for the Years 2008 & 2012
Table 21: The German Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 22: Percentage Breakdown of the German Market for HbA1c
Monitoring by Type for the Years 2008 & 2012
Table 23: The Italian Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 24: Percentage Breakdown of the Italian Market for
HbA1c Monitoring by Type for the Years 2008 & 2012
Table 25: The UK Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 26: Percentage Breakdown of the UK Market for HbA1c
Monitoring by Type for the Years 2008 & 2012
Table 27: The Spanish Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 28: Percentage Breakdown of Spanish Market for HbA1c
Monitoring by Type for the Years 2008 & 2012
Table 29: The Russian Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 30: Percentage Breakdown of Russian Market for HbA1c
Monitoring by Type for the Years 2008 & 2012
Table 31: The Rest of Europe Market for HbA1c Monitoring by
Type: 2007-2015 (Sales in US$ Million)
Table 32: Percentage Breakdown of Rest of Europe Market for
HbA1c Monitoring by Type for the Years 2008 & 2012
Table 33: The Asia-Pacific (excluding Japan) Market for HbA1c
Monitoring by Type: 2007-2015 (Sales in US$ Million)
Table 34: Percentage Breakdown of Asia- Pacific (excluding
Japan) Market for HbA1c Monitoring by Type for the Years 2008
& 2012
Table 35: The Middle East Market for HbA1c Monitoring by Type:
2007-2015 (Sales in US$ Million)
Table 36: Percentage Breakdown of Middle East Market for HbA1c
Monitoring by Type for the Years 2008 & 2012
Table 37: The Latin American Market for HbA1c Monitoring by
Type: 2007-2015 (Sales in US$ Million)
Table 38: Percentage Breakdown of Latin American Market for
HbA1c Monitoring by Type for the Years 2008 & 2012
Table 39: The Rest of World Market for HbA1c Monitoring by
Type: 2007-2015 (Sales in US$ Million)
Table 40: Percentage Breakdown of Rest of World Market for
HbA1c Monitoring by Type for the Years 2008 & 2012
COMPANIES PROFILED
To order this report:
Diagnostics Industry: Hemoglobin A1c Monitoring - Global Market Trends
More Market Research Report
Contact: Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker